PRESS RELEASE published on 11/15/2024 at 22:00, 6 months 13 days ago Inventiva présentera lors de la session « late-breaker » de l'AASLD The Liver Meeting®, les résultats de l'analyse finale de la Phase 2 évaluant la combinaison de lanifibranor avec empagliflozine chez des patients atteints de MASH et DT2 Inventiva présente les résultats de l'étude LEGEND sur lanifibranor et empagliflozine pour MASH et diabète de type 2 à l'AASLD The Liver Meeting®. Améliorations notables notamment sur HbA1c, stéatose hépatique et santé cardiométabolique Inventiva MASH Lanifibranor Empagliflozine Étude LEGEND
BRIEF published on 10/30/2024 at 21:05, 6 months 29 days ago Inventiva's Stock Rises Following Positive Update on Lanifibranor Trial Inventiva MASH Lanifibranor NATiV3 Clinical Trial DMC Recommendation
BRIEF published on 10/30/2024 at 21:05, 6 months 29 days ago Hausse des actions d'Inventiva suite à une mise à jour positive sur l'essai Lanifibranor Inventive Lanifibranor Essai Clinique NATiV3 ÉCRASER Recommandation DMC
PRESS RELEASE published on 10/30/2024 at 21:00, 6 months 29 days ago Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH Inventiva receives positive recommendation from fifth DMC review for lanifibranor in MASH Phase 3 trial, confirming good safety profile Safety Data Inventiva MASH Lanifibranor Positive Recommendation
PRESS RELEASE published on 10/30/2024 at 21:00, 6 months 29 days ago Inventiva annonce la recommandation positive du cinquième DMC de l’étude clinique NATiV3 Phase 3 avec lanifibranor dans la MASH Inventiva obtient recommandation positive du 5ème DMC pour continuer étude clinique Phase 3 NATiV3 avec lanifibranor dans la MASH, confirmant bon profil de sécurité du traitement Étude Clinique Inventiva MASH Lanifibranor DMC
BRIEF published on 10/23/2024 at 11:38, 7 months 6 days ago Invus Public Equities dépasse les seuils chez Inventiva Droits De Vote Augmentation De Capital Franchissement De Seuils Inventiva Invus Public Equities
BRIEF published on 10/23/2024 at 11:38, 7 months 6 days ago Invus Public Equities exceeds thresholds at Inventiva Voting Rights Capital Increase Crossing Thresholds Inventiva Invus Public Equities
BRIEF published on 10/23/2024 at 11:36, 7 months 6 days ago Franchissement de seuils par BVF Partners dans le capital d'Inventiva Droits De Vote Augmentation De Capital Franchissement De Seuils Inventiva BVF Partners
BRIEF published on 10/23/2024 at 11:36, 7 months 6 days ago BVF Partners Crosses Thresholds in Inventiva's Capital Voting Rights Capital Increase Crossing Thresholds Inventiva BVF Partners
PRESS RELEASE published on 10/23/2024 at 11:33, 7 months 6 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, LP. concernant Inventiva, suite à une augmentation de capital Augmentation De Capital Franchissement De Seuils Inventiva Invus Public Equities
Published on 05/29/2025 at 15:00, 5 hours 3 minutes ago Elvictor Group Reports Strong Growth in Seafarer Deployment and Client Base, Projects Significant Expansion in 2025
Published on 05/29/2025 at 15:00, 5 hours 3 minutes ago E-Cite Motors Approved for Upgrade to OTCID Tier - Ticker Symbol to Transition to (OTCID:VAPR) on July 1st, 2025
Published on 05/29/2025 at 14:30, 5 hours 33 minutes ago NV Gold Announces Drill Program at the Slumber Gold Project in Nevada
Published on 05/29/2025 at 14:30, 5 hours 33 minutes ago Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints
Published on 05/29/2025 at 14:00, 6 hours 3 minutes ago GameSquare's Stream Hatchet Redefines Gaming Analytics with Breakthrough AI-Powered Data Ecosystem
Published on 05/29/2025 at 18:48, 1 hour 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/29/2025 at 18:32, 1 hour 30 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/29/2025 at 18:15, 1 hour 47 minutes ago Funding Circle Holdings plc: HOL-Holding(s) in Company
Published on 05/29/2025 at 18:15, 1 hour 47 minutes ago Moonkie Unveils Hug & Go Toddler Backpack Ahead of International Children's Day
Published on 05/29/2025 at 17:45, 2 hours 18 minutes ago Argyle Resources Corp. Announces Preliminary Remote Sensing Results for Matapedia Silica Project, Quebec
Published on 05/28/2025 at 23:00, 21 hours 3 minutes ago Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 21 hours 3 minutes ago Engagements collectifs de conservation de titres de la société
Published on 05/28/2025 at 18:39, 1 day 1 hour ago Descriptif du programme de rachat d'actions - Mai 2025
Published on 05/28/2025 at 18:34, 1 day 1 hour ago AXA a placé 1 milliard d’euros d’Obligations Restricted Tier 1 et 1 milliard d’euros d’Obligations Tier 2